InsiderClue
← All stocks

OMEROS CORP

OMER Mostly scheduled
CIK 0001285819 #2345 in the set updated 17 Sep 2026
Bought (120 mo)
$40.50K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$18.93M
$0.00 on a plan · $18.21M straight out of an exercise
Sold at will
$726.83K
5 of 51 sales
Net
−$18.89M
−$686.33K against sales at will

By person

10 insiders · 69 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Demopulos Gregory A MD
Chairman, CEO & President
$25.20K (1)
$10.39M (13) scheduled
−$10.36M
1,769,308
2.44%
$32.81M
+33.4%
Kelbon Marcia S.
VP Patent and General Counsel
—
$3.36M (7) scheduled
−$3.36M
210,645
0.2910%
$3.91M
+28.8%
JACOBSEN MICHAEL A
VP, Finance & CAO
—
$2.04M (11) scheduled
−$2.04M
14,000
0.0193%
$259.58K
—
Borges David J.
VP, Finance & CAO
—
$1.04M (5) scheduled
−$1.04M
0
0.0000%
$0.00
−100.0%
Cancelmo Peter B
VP, General Counsel
—
$929.67K (2) scheduled
−$929.67K
200
0.0003%
$3.71K
0.0%
Cable Thomas J.
Director
—
$853.16K (9) scheduled
−$853.16K
35,067
0.0484%
$650.20K
−23.9%
HANISH ARNOLD C
Director
—
$314.39K (4) scheduled
−$314.39K
22,400
0.0309%
$415.33K
+80.6%
Demopulos Peter A MD
Director
$15.30K (1)
—
+$15.30K
372,898
0.5151%
$6.91M
+6.7%
Hood Leroy E. MD PhD
Director
—
—
—
74,390
0.1028%
$1.38M
+36.8%
Bumol Thomas F.
Director
—
—
—
10,000
0.0138%
$185.42K
—

Individual transactions

69
Insider
Date
Role
Action
Shares
Price
Amount
Cancelmo Peter B
31 Aug 2026
VP, General Counsel
Sold after exercise
25,000
$18.54
$463.54K
Cancelmo Peter B
28 Aug 2026
VP, General Counsel
Sold after exercise
25,000
$18.65
$466.13K
HANISH ARNOLD C
27 Aug 2026
Director
Sold after exercise
5,000
$19.02
$95.08K
HANISH ARNOLD C
27 Aug 2026
Director
Sold after exercise
5,000
$18.88
$94.38K
HANISH ARNOLD C
26 Aug 2026
Director
Sold after exercise
5,000
$18.53
$92.63K
Borges David J.
24 Aug 2026
VP, Finance & CAO
Sold after exercise
906
$19.10
$17.30K
Borges David J.
21 Aug 2026
VP, Finance & CAO
Sold after exercise
10,000
$18.95
$189.50K
Cable Thomas J.
20 Aug 2026
Director
Sold after exercise
15,000
$18.45
$276.77K
Borges David J.
13 Aug 2026
VP, Finance & CAO
Sold after exercise
5,000
$16.95
$84.75K
Cable Thomas J.
22 May 2026
Director
Sold after exercise
7,500
$11.61
$87.04K
Demopulos Gregory A MD
18 Feb 2026
Chairman, CEO & President
Exercised, kept
400,000
$10.27
$4.11M
Borges David J.
13 Jan 2026
VP, Finance & CAO
Sold after exercise
30,000
$12.31
$369.32K
Borges David J.
12 Jan 2026
VP, Finance & CAO
Sell
30,000
$12.72
$381.60K
Demopulos Gregory A MD
17 Nov 2023
Chairman, CEO & President
Buy indirect
15,000
$1.68
$25.20K
Demopulos Peter A MD
15 Nov 2023
Director
Buy
10,000
$1.53
$15.30K
Cable Thomas J.
22 May 2023
Director
Sold after exercise
5,000
$6.53
$32.65K
HANISH ARNOLD C
22 May 2023
Director
Sold after exercise
5,000
$6.46
$32.30K
HANISH ARNOLD C
8 Sep 2021
Director
Exercised, kept indirect
10,000
$9.44
$94.40K
Demopulos Gregory A MD
17 Jun 2021
CHAIRMAN, CEO & PRESIDENT
Sold after exercise
36,857
$14.90
$549.17K
Demopulos Gregory A MD
15 Jun 2021
CHAIRMAN, CEO & PRESIDENT
Sold after exercise
36,856
$15.02
$553.58K
Demopulos Gregory A MD
20 May 2021
CHAIRMAN, CEO & PRESIDENT
Sold after exercise
36,856
$14.96
$551.37K
Demopulos Gregory A MD
19 May 2021
CHAIRMAN, CEO & PRESIDENT
Sold after exercise
36,857
$17.07
$629.15K
Demopulos Gregory A MD
8 Apr 2021
CHAIRMAN, CEO & PRESIDENT
Sold after exercise
35,206
$17.76
$625.26K
Demopulos Gregory A MD
7 Apr 2021
CHAIRMAN, CEO & PRESIDENT
Sold after exercise
37,407
$17.91
$669.96K
JACOBSEN MICHAEL A
22 Feb 2021
VP FINANCE AND CAO
Sold after exercise
8,100
$23.28
$188.57K
Demopulos Peter A MD
22 Feb 2021
Director
Exercised, kept
5,000
$4.53
$22.65K
Demopulos Peter A MD
22 Feb 2021
Director
Exercised, kept
5,000
$5.30
$26.50K
JACOBSEN MICHAEL A
19 Feb 2021
VP FINANCE AND CAO
Sold after exercise
10,000
$22.64
$226.40K
Hood Leroy E. MD PhD
12 Feb 2021
Director
Exercised, kept
5,000
$4.53
$22.65K
JACOBSEN MICHAEL A
10 Feb 2021
VP FINANCE AND CAO
Sold after exercise
1,900
$22.49
$42.73K
JACOBSEN MICHAEL A
20 Jan 2021
VP FINANCE AND CAO
Exercised, kept
10,000
$9.37
$93.70K
JACOBSEN MICHAEL A
19 Jan 2021
VP FINANCE AND CAO
Sell
9,500
$19.95
$189.53K
Cable Thomas J.
13 Jan 2021
Director
Sold after exercise
5,000
$16.97
$84.85K
Cable Thomas J.
13 May 2020
Director
Sold after exercise
5,000
$14.40
$72.00K
Hood Leroy E. MD PhD
13 Mar 2020
Director
Exercised, kept
5,000
$5.92
$29.60K
Demopulos Peter A MD
14 Dec 2019
Director
Exercised, kept
3,334
$7.56
$25.21K
Hood Leroy E. MD PhD
14 Dec 2019
Director
Exercised, kept
10,000
$7.56
$75.60K
Cable Thomas J.
3 Dec 2019
Director
Sold after exercise
10,000
$14.41
$144.15K
Cable Thomas J.
14 Oct 2019
Director
Sell
5,000
$15.12
$75.59K
Kelbon Marcia S.
7 Jun 2019
VP Patent and General Counsel
Exercised, kept
10,000
$6.05
$60.50K
Kelbon Marcia S.
31 Aug 2018
VP Patent and General Counsel
Sold after exercise
5,337
$25.93
$138.38K
Kelbon Marcia S.
31 Aug 2018
VP Patent and General Counsel
Sold after exercise
2,192
$25.31
$55.47K
Kelbon Marcia S.
30 Aug 2018
VP Patent and General Counsel
Sold after exercise
35,000
$24.45
$855.75K
Kelbon Marcia S.
27 Jul 2018
VP Patent and General Counsel
Sold after exercise
5,723
$21.73
$124.36K
Kelbon Marcia S.
26 Jul 2018
VP Patent and General Counsel
Sold after exercise
35,000
$21.53
$753.69K
Kelbon Marcia S.
12 Jul 2018
VP Patent and General Counsel
Sold after exercise
4,277
$21.48
$91.89K
JACOBSEN MICHAEL A
15 May 2018
VP Finance and CAO
Sold after exercise
12,812
$24.95
$319.66K
JACOBSEN MICHAEL A
14 May 2018
VP Finance and CAO
Sold after exercise
10,980
$22.45
$246.50K
JACOBSEN MICHAEL A
4 Jan 2018
VP Finance and CAO
Exercised, kept
1,000
$9.37
$9.37K
JACOBSEN MICHAEL A
3 Jan 2018
VP Finance and CAO
Sold after exercise
1,020
$22.45
$22.90K
Kelbon Marcia S.
3 Jan 2018
VP Patent and General Counsel
Sold after exercise
62,528
$21.45
$1.34M
Demopulos Gregory A MD
28 Dec 2017
Chairman, CEO & President
Exercised, kept
39,961
$4.10
$163.84K
Demopulos Gregory A MD
28 Dec 2017
Chairman, CEO & President
Exercised, kept
102,040
$2.45
$250.00K
Kelbon Marcia S.
21 Aug 2017
VP Patent and General Counsel
Exercised, kept
8,000
$6.05
$48.40K
JACOBSEN MICHAEL A
16 Jun 2017
VP Finance and CAO
Sold after exercise
12,000
$24.95
$299.40K
JACOBSEN MICHAEL A
15 Jun 2017
VP Finance and CAO
Sold after exercise
12,000
$22.45
$269.40K
JACOBSEN MICHAEL A
14 Jun 2017
VP Finance and CAO
Sold after exercise
9,350
$19.95
$186.53K
JACOBSEN MICHAEL A
13 Jun 2017
VP Finance and CAO
Sold after exercise
2,650
$19.95
$52.87K
Cable Thomas J.
12 Apr 2017
Director
Sell
3,000
$16.49
$49.47K
Kelbon Marcia S.
20 Mar 2017
VP Patent and General Counsel
Exercised, kept
2,040
$6.05
$12.34K
Cable Thomas J.
14 Dec 2016
Director
Sell
3,000
$10.21
$30.64K
Demopulos Gregory A MD
7 Dec 2016
Chairman, CEO & President
Sold after exercise
102,044
$10.48
$1.07M
Demopulos Gregory A MD
6 Dec 2016
Chairman, CEO & President
Sold after exercise
102,040
$10.80
$1.10M
Demopulos Gregory A MD
5 Dec 2016
Chairman, CEO & President
Sold after exercise
102,040
$10.71
$1.09M
Demopulos Gregory A MD
2 Dec 2016
Chairman, CEO & President
Sold after exercise
102,040
$11.00
$1.12M
Demopulos Gregory A MD
1 Dec 2016
Chairman, CEO & President
Sold after exercise
999
$12.32
$12.30K
Demopulos Gregory A MD
1 Dec 2016
Chairman, CEO & President
Sold after exercise
105,522
$11.56
$1.22M
Demopulos Gregory A MD
30 Nov 2016
Chairman, CEO & President
Sold after exercise
97,559
$12.21
$1.19M
Kelbon Marcia S.
12 Oct 2016
VP Patent and General Counsel
Exercised, kept
3,004
$6.05
$18.17K

What was left out

Form 4 filings counted 160
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 46
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 3,693,782
Sales filed before the plan box existed 4
History held since 16 Sep 2016